Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: CRC, Bowel Cancer, Colon Cancer, Rectal Cancer
Colorectal cancer (CRC) arises from the epithelial cells lining the colon or rectum. It typically begins as benign growths called polyps, which may evolve into invasive adenocarcinoma over several years. It is one of the most common malignancies globally, characterized by high treatability if detected via screening at early stages.
CRC development is driven by a combination of sporadic mutations (90%) and inherited genetic syndromes (10%). Lifestyle factors such as high red meat consumption, low fiber intake, obesity, smoking, and chronic alcohol use contribute significantly.
The transition from normal mucosa to carcinoma follows the "adenoma-carcinoma sequence." It involves sequential genetic mutations: loss of the APC tumor suppressor gene, activation of the KRAS oncogene, and deletion of the p53 tumor suppressor gene. This leads to unregulated cellular proliferation and inhibited apoptosis within the intestinal crypts.
CRC is the third most common cancer worldwide. Incidence increases significantly after age 50, though rates in younger populations are rising. Men are slightly more affected than women.
Age >50, family history, inflammatory bowel disease (IBD), type 2 diabetes, sedentary lifestyle, high-fat/low-fiber diet, and genetic syndromes (Lynch syndrome, FAP).
A. Early Symptoms
Pallor (anemia), abdominal tenderness, palpable masses on digital rectal examination (DRE), or hepatomegaly indicating metastatic disease.
A. Clinical Assessment: History and physical exam.
B. Laboratory Testing: CBC, liver function tests, CEA.
C. Imaging Studies: CT scan of chest/abdomen/pelvis.
D. Functional Tests: Colonoscopy (gold standard).
E. Biopsy Findings: Histopathology (adenocarcinoma).
F. Genetic Testing: Microsatellite instability (MSI), MMR proteins.
G. Differential Diagnosis: Crohn's disease, ulcerative colitis, diverticulitis, IBS.
Carcinoembryonic Antigen (CEA)
Type: Blood Test
Purpose: Monitor treatment response and recurrence.
Expected Findings: Elevated levels in advanced disease.
Interpretation: Not diagnostic for primary detection; used for post-treatment surveillance.
Colonoscopy: Gold standard for visualization and biopsy.
CT Chest/Abdomen/Pelvis: Primary method for staging and identifying metastases.
Diverticulitis (often acute/inflammatory), Inflammatory Bowel Disease (chronic), Hemorrhoids (bright red blood).
Bowel obstruction, perforation, fistulas, distant metastases (liver, lungs), and treatment-related toxicities (neuropathy, myelosuppression).
A. Lifestyle Modifications: High fiber, smoking cessation.
B. Preventive Measures: Screening colonoscopy.
C. Medical Treatment
Highly dependent on stage at diagnosis. Localized disease (Stage I) has a 5-year survival rate >90%, while metastatic (Stage IV) is approximately 14%.
Screening colonoscopy starting at age 45 (average risk); fecal immunochemical testing (FIT).
The following homeopathic remedies have been historically indicated for symptoms associated with Colorectal Cancer. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Colorectal Cancer.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.
Browse our full library of 200+ medical and pathology calculators.
📊 Browse All CalculatorsSpeak with our specialists for a customized treatment protocol for this condition.
📅 Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.